Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
about
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerA RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.Role of CD44 in tumour progression and strategies for targeting.Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.
P2860
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@en
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@nl
type
label
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@en
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@nl
prefLabel
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@en
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@nl
P2093
P2860
P1476
Development of a hyaluronan bioconjugate for the topical treatment of melanoma.
@en
P2093
Henry J Greyner
Li-Shu Zhang
Mark E Mummert
W Matthew Petroll
P2860
P356
10.1016/J.JDERMSCI.2009.02.014
P577
2009-04-05T00:00:00Z